CASºÅ²éѯ»¯¹¤²úÆ·

ÈÈÃÅËÑË÷»¯Ñ§Æ·×î¶àÖ»ÏÔʾǰ20Ìõ£¬Çëµã»÷¡°ËÑË÷»¯Ñ§Æ·¡±²é¿´ËùÓнá¹û


CASµÇ¼ºÅ ÖÐÎÄÃû Ó¢ÎÄÃû ·Ö×ӽṹʽ ·Ö×Óʽ ÏêÇé ¹©Ó¦ÉÌ
126601-86-3Cleromyrin II (9CI);
Dipyrrolo[1,2-a:1',2'-g][1,4,7,10,13,16]hexaazaCyclooctadecine,cyclic peptide deriv.;
Cyclo(glycyl-L-prolyl-L-leucyl-L-prolylglycyl-L-tyrosyl)
CAS:126601-86-3»¯Ñ§½á¹¹C29H40N6O7ÏêÇ鹩ӦÉÌ
31556-84-0Monamycin I (8CI,9CI);
2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazaCyclooctadecine,cyclic peptide deriv.;
D-Isoleucine, N-[1-[N-[[2-[[D-trans-5-chlorohexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-,p-lactone;
N-[1-[N-[[2-[[D-trans-5-Chlorohexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-D-isoleucinep-lactone
CAS:31556-84-0»¯Ñ§½á¹¹C35H58ClN7O8ÏêÇ鹩ӦÉÌ
31556-81-7Monamycin G2 (8CI,9CI);
2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazaCyclooctadecine,cyclic peptide deriv.;
D-Isoleucine, N-[1-[N-[[2-[[D-trans-5-chlorohexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-,p-lactone;
N-[1-[N-[[2-[[D-trans-5-Chlorohexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-D-isoleucinep-lactone
CAS:31556-81-7»¯Ñ§½á¹¹C33H54ClN7O8ÏêÇ鹩ӦÉÌ
31556-77-1Monamycin B3 (8CI,9CI);
2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazaCyclooctadecine,cyclic peptide deriv.;
D-Valine, N-[1-[N-[[2-[[D-hexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-,p-lactone;
N-[1-[N-[[2-[[D-Hexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-D-valinep-lactone
CAS:31556-77-1»¯Ñ§½á¹¹C33H55N7O8ÏêÇ鹩ӦÉÌ
31594-06-6Monamycin H1 (8CI,9CI);
2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazaCyclooctadecine,cyclic peptide deriv.;
D-Valine, N-[1-[N-[[2-[[D-trans-5-chlorohexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-,p-lactone;
N-[1-[N-[[2-[[D-trans-5-Chlorohexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-D-valinep-lactone
CAS:31594-06-6»¯Ñ§½á¹¹C34H56ClN7O8ÏêÇ鹩ӦÉÌ
31556-79-3Monamycin D2 (8CI,9CI);
2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazaCyclooctadecine,cyclic peptide deriv.;
D-Isoleucine, N-[1-[N-[[2-[[D-hexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-,p-lactone;
N-[1-[N-[[2-[[D-Hexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-D-isoleucinep-lactone
CAS:31556-79-3»¯Ñ§½á¹¹C34H57N7O8ÏêÇ鹩ӦÉÌ
31556-82-8Monamycin G3 (8CI,9CI);
2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazaCyclooctadecine,cyclic peptide deriv.;
D-Valine, N-[1-[N-[[2-[[D-trans-5-chlorohexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-,p-lactone;
N-[1-[N-[[2-[[D-trans-5-Chlorohexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-D-valinep-lactone
CAS:31556-82-8»¯Ñ§½á¹¹C33H54ClN7O8ÏêÇ鹩ӦÉÌ
28045-02-5Monamycin D1 (8CI,9CI);
2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazaCyclooctadecine,cyclic peptide deriv.;
D-Valine, N-[1-[N-[[2-[[D-hexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-,p-lactone;
N-[1-[N-[[2-[[D-Hexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-D-valinep-lactone
CAS:28045-02-5»¯Ñ§½á¹¹C34H57N7O8ÏêÇ鹩ӦÉÌ
31556-83-9Monamycin H2 (8CI,9CI);
2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazaCyclooctadecine,cyclic peptide deriv.;
D-Isoleucine, N-[1-[N-[[2-[[D-trans-5-chlorohexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-,p-lactone;
N-[1-[N-[[2-[[D-trans-5-Chlorohexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-D-isoleucinep-lactone
CAS:31556-83-9»¯Ñ§½á¹¹C34H56ClN7O8ÏêÇ鹩ӦÉÌ
31556-76-0Monamycin B2 (8CI,9CI);
2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazaCyclooctadecine,cyclic peptide deriv.;
D-Isoleucine, N-[1-[N-[[2-[[D-hexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-,p-lactone;
N-[1-[N-[[2-[[D-Hexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-L-prolyl]-D-isoleucinep-lactone
CAS:31556-76-0»¯Ñ§½á¹¹C33H55N7O8ÏêÇ鹩ӦÉÌ
31556-75-9Monamycin B1 (8CI,9CI);
2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazaCyclooctadecine,cyclic peptide deriv.;
D-Valine, N-[1-[N-[[2-[[D-hexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-,p-lactone;
N-[1-[N-[[2-[[D-Hexahydro-2-(L-2-hydroxy-3-methyl-1-oxobutyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-D-valinep-lactone
CAS:31556-75-9»¯Ñ§½á¹¹C33H55N7O8ÏêÇ鹩ӦÉÌ
31594-05-5Monamycin F (8CI,9CI);
2H-Dipyridazino[1,6-d:1',6'-g]pyrrolo[1,2-m][1,4,7,10,13,16]oxapentaazaCyclooctadecine,cyclic peptide deriv.;
D-Isoleucine, N-[1-[N-[[2-[[D-hexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-,p-lactone;
N-[1-[N-[[2-[[D-Hexahydro-2-(L-erythro-2-hydroxy-3-methyl-1-oxopentyl)-3-pyridazinyl]carbonyl]-L-hexahydro-cis-5-hydroxy-3-pyridazinyl]carbonyl]-N-methyl-D-leucyl]-trans-4-methyl-L-prolyl]-D-isoleucinep-lactone
CAS:31594-05-5»¯Ñ§½á¹¹C35H59N7O8ÏêÇ鹩ӦÉÌ
40471-97-45,6,14,15-DIBENZO-4,7,13,16,21,24-HEXAOXA-1,10-DIAZABICYCLO[8.8.8]HEXACOSANE;
5,6,14,15-DIBENZO-4,7,13,16,21,24-HEXAOXA-1,10-DIAZABICYCLO[8.8.8]HEXACOSANE;
KRYPTOFIX 222 BB;
KRYPTOFIX(R) 222 BB;
6,7,9,10,17,18,20,21-octahydro-8,19-(ethanoxyethanoxyethano)-8H,19H-dibenzo[b,k][1,4,10,13,7,16]tetraoxadiazaCyclooctadecine;
KRYPTOFIX 222 BB 99+%;
8,19-(Ethanoxyethanoxyethano)-8H,19H-dibenzob,k1,4,10,13,7,16tetraoxadiazaCyclooctadecine, 6,7,9,10,17,18,20,21-octahydro-;
5,6:14,15-Bis(2-butene-1,4-diylidene)-1,10-diaza-4,7,13,16,21,24-hexaoxabicyclo[8.8.8]hexacosane;
6,7,9,10,17,18,20,21-Octahydro-8,19-(ethanoxyethanoxyethano)-8H,19H-dibenzo[b,k][1,4,10,13,7,16]tetraoxadiazaCyclooctadecine
CAS:40471-97-4·Ö×ӽṹC26H44N2O6ÏêÇ鹩ӦÉÌ
ÈÈÃÅËѹؼü´Ê:Decarboxy CETIOL HE ¶þ °· Íé DMAG fenil Damasceno boil Fatty acids ¦Ã- ÑÇÓÍËá EC 321€ Oil soluble Docosadienoic acid CH2OHCHOHCH2OH nolide N-ACETYL CYSTEINE 2-±ûÏ©Ëá¶¡õ¥Óë±½ÒÒÏ©ºÍ±ûÏ©ëæµÄ¾ÛºÏÎï Butano C12H22O9 ÈõËáÐÔ ½»»»Ê÷Ö¬ triflat 6-ôÇ»ù-2- ÂÈ °±»ù ±½¼×Ëá¼×õ¥ C6H4O5N2 ¾Û´×ËáÒÒÏ©õ¥ CAS NO Âȼ×Ëá ´¼õ¥ meso Ë«·Ó ·ÓÈ©»·ÑõÊ÷Ö¬ fentany PORON polyoxy D-ÏËά¶þÌÇ; ²¢¡¤ÅðËáõ¥ AsNo ¼×»ù±½¶¡Íª Ethyl levulinate ÁÚÜÐÑõ»ù±½¼×È© ßÁ૸ʶÌÇ CH3COCH2CHO ÒÒ»ù¶þÂÈ»¯Á× ¶þ»·[4.1.0]¸ýÍé